Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Trial of Liquid Biopsy for Malignant Peripheral Nerve Sheath Tumor (MPNST) Among Participants With Neurofibromatosis Type 1

NCT06515860 is registered in ClinicalTrials.gov with David Miller as lead sponsor.

NCT NCT06515860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06515860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Trial of Liquid Biopsy for Malignant Peripheral Nerve Sheath Tumor (MPNST) Among Participants With Neurofibromatosis Type 1
Lead sponsor
David Miller
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 7, 2024
Completion date
July 31, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical neurofibroma, malignant peripheral nerve sheath tumor, malignant peripheral nerve sheath tumors, neurofibromatosis 1, neurofibromatosis type 1, plexiform neurofibroma, plexiform neurofibromas